tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BCAB Stock Latest News

BioAtla presents data from ongoing dose escalation fo BA3182
The FlyBioAtla presents data from ongoing dose escalation fo BA3182
3d ago
BCAB
BioAtla Approves 2025 Corporate Bonus Plan
PremiumCompany Announcements
BioAtla Approves 2025 Corporate Bonus Plan
16d ago
8K
BCAB
BioAtla presents Phase 2 Oz-V clinical trial data at ASCO 2025
PremiumThe Fly
BioAtla presents Phase 2 Oz-V clinical trial data at ASCO 2025
1M ago
BCAB
BioAtla Receives Nasdaq Non-Compliance Notice
PremiumCompany Announcements
BioAtla Receives Nasdaq Non-Compliance Notice
2M ago
8K
BCAB
BioAtla, Inc. Reports Q1 2025 Financial Results
PremiumCompany Announcements
BioAtla, Inc. Reports Q1 2025 Financial Results
2M ago
BCAB
Bioatla, Inc. Earnings Call Highlights Clinical Success
PremiumCompany AnnouncementsBioatla, Inc. Earnings Call Highlights Clinical Success
2M ago
BCAB
BioAtla files to sell 9.68M shares of common stock for holders
Premium
The Fly
BioAtla files to sell 9.68M shares of common stock for holders
2M ago
BCAB
BioAtla reports Q1 EPS (26c), consensus (29c)
Premium
The Fly
BioAtla reports Q1 EPS (26c), consensus (29c)
2M ago
BCAB
BioAtla announces poster presentations at 2025 AACR meeting
PremiumThe Fly
BioAtla announces poster presentations at 2025 AACR meeting
2M ago
BCAB
BioAtla price target lowered to $1 from $5 at Citizens JMP
PremiumThe Fly
BioAtla price target lowered to $1 from $5 at Citizens JMP
3M ago
BCAB
BioAtla’s Earnings Call: Clinical Progress and Strategic Outlook
PremiumCompany Announcements
BioAtla’s Earnings Call: Clinical Progress and Strategic Outlook
3M ago
BCAB
Positive Outlook for BioAtla: Strategic Moves and Promising Developments Signal Potential Upside
PremiumRatings
Positive Outlook for BioAtla: Strategic Moves and Promising Developments Signal Potential Upside
3M ago
BCAB
BioAtla price target lowered to $10 from $13 at BTIG
PremiumThe FlyBioAtla price target lowered to $10 from $13 at BTIG
3M ago
BCAB
BioAtla, Inc. Reports 2024 Financial Results and Clinical Progress
Premium
Company Announcements
BioAtla, Inc. Reports 2024 Financial Results and Clinical Progress
3M ago
BCAB
BioAtla announces restructuring, to cut over 30% of workforce
Premium
The Fly
BioAtla announces restructuring, to cut over 30% of workforce
3M ago
BCAB
BioAtla reports Q4 Net loss ($14.9M) vs ($26.9M) last year
PremiumThe Fly
BioAtla reports Q4 Net loss ($14.9M) vs ($26.9M) last year
3M ago
BCAB
BCAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
BCAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
BCAB
BioAtla Awards Executive Bonuses and Stock Units
PremiumCompany Announcements
BioAtla Awards Executive Bonuses and Stock Units
4M ago
8K
BCAB
BioAtla Secures $9.2M for Clinical Program Advancements
PremiumCompany Announcements
BioAtla Secures $9.2M for Clinical Program Advancements
7M ago
8K
BCAB
BioAtla Highlights Advancements in CAB Cancer Therapy
PremiumCompany AnnouncementsBioAtla Highlights Advancements in CAB Cancer Therapy
7M ago
8K
BCAB
BioAtla to sell 9.68M shares at 95.2c in registered direct offering
Premium
The Fly
BioAtla to sell 9.68M shares at 95.2c in registered direct offering
7M ago
BCAB
BioAtla presents data on mecbotamab vedotin in advanced NSCLC
Premium
The Fly
BioAtla presents data on mecbotamab vedotin in advanced NSCLC
7M ago
BCAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >